| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |